A detailed history of Satovsky Asset Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Satovsky Asset Management LLC holds 12,117 shares of PFE stock, worth $363,146. This represents 0.1% of its overall portfolio holdings.

Number of Shares
12,117
Previous 11,790 2.77%
Holding current value
$363,146
Previous $339,000 0.88%
% of portfolio
0.1%
Previous 0.11%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$25.89 - $29.73 $8,466 - $9,721
327 Added 2.77%
12,117 $336,000
Q4 2023

Jan 23, 2024

BUY
$26.13 - $33.94 $4,128 - $5,362
158 Added 1.36%
11,790 $339,000
Q3 2023

Oct 23, 2023

BUY
$32.09 - $37.51 $2,599 - $3,038
81 Added 0.7%
11,632 $385,000
Q2 2023

Jul 28, 2023

BUY
$36.12 - $41.79 $24,453 - $28,291
677 Added 6.23%
11,551 $423,000
Q1 2023

Apr 26, 2023

BUY
$39.39 - $51.28 $4,293 - $5,589
109 Added 1.01%
10,874 $443,000
Q4 2022

Jan 24, 2023

BUY
$41.75 - $54.5 $3,674 - $4,796
88 Added 0.82%
10,765 $0
Q3 2022

Oct 21, 2022

BUY
$43.76 - $53.42 $4,025 - $4,914
92 Added 0.87%
10,677 $467,000
Q2 2022

Aug 02, 2022

SELL
$46.53 - $55.17 $1,023 - $1,213
-22 Reduced 0.21%
10,585 $555,000
Q1 2022

May 03, 2022

BUY
$45.75 - $56.69 $8,601 - $10,657
188 Added 1.8%
10,607 $549,000
Q4 2021

Feb 07, 2022

BUY
$41.32 - $61.25 $3,099 - $4,593
75 Added 0.73%
10,419 $615,000
Q3 2021

Nov 08, 2021

BUY
$39.25 - $50.42 $3,375 - $4,336
86 Added 0.84%
10,344 $445,000
Q2 2021

Aug 05, 2021

BUY
$35.91 - $40.68 $3,698 - $4,190
103 Added 1.01%
10,258 $402,000
Q1 2021

May 05, 2021

BUY
$33.49 - $37.77 $5,626 - $6,345
168 Added 1.68%
10,155 $368,000
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $334,264 - $425,046
9,987 New
9,987 $368,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $168B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Satovsky Asset Management LLC Portfolio

Follow Satovsky Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Satovsky Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Satovsky Asset Management LLC with notifications on news.